Trial Profile
the effect of tofacitinib on bone mineral density in patients with rheumatoid arthritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2017
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 08 May 2017 New trial record